CC BY-NC-ND 4.0 · Indian J Plast Surg 2006; 39(02): 179-181
DOI: 10.1055/s-0039-1699154
Case Report
Association of Plastic Surgeons of India

Diagnostic dilemma in Kaposi’s sarcoma

Rao B.S Satish
Department of General Surgery, Fr. Muller Medical College Hospital, Kankanady, Mangalore - 2, Karnataka, India
,
Tauro F Leo
Department of General Surgery, Fr. Muller Medical College Hospital, Kankanady, Mangalore - 2, Karnataka, India
,
Menezes Theobald Leo
Department of General Surgery, Fr. Muller Medical College Hospital, Kankanady, Mangalore - 2, Karnataka, India
,
B Nandakishore
Department of General Surgery, Fr. Muller Medical College Hospital, Kankanady, Mangalore - 2, Karnataka, India
,
K Praveen Kumar
Department of General Surgery, Fr. Muller Medical College Hospital, Kankanady, Mangalore - 2, Karnataka, India
› Author Affiliations
Further Information

Publication History

Publication Date:
14 May 2020 (online)

ABSTRACT

Kaposi′s sarcoma is described as cutaneous and extracutaneous neoplasm predominantly affecting older individuals. Though earlier uncommon and endemic to certain African areas, its incidence is on a rise due to infections with human immunodeficiency virus and also due to transplant-associated immunosuppression. Further, certain benign conditions like Pseudo Kaposi′s sarcoma, certain infective conditions like bacillary angiomatosis of acquired immunodeficiency syndrome can mimic Kaposi′s sarcoma both clinically and histologically leading to a diagnostic dilemma. We report such a case here.

 
  • 1 Beral V, Peterman TA, Berkelman R, Jaffe HW. Kaposi’s sarcoma among persons with AIDS: A sexually transmitted infection?. Lancet 1990; 335: 123-8
  • 2 Kestens L. Endemic African Kaposi’s Sarcoma is not associated with immunodeficiency. Int J Cancer. 1986 36. 49
  • 3 Penn I. The changing pattern of post transplant malignancies. Transplant Proc 1991; 23: 1101-3
  • 4 Deichmann M, Thome M, Jackel A, Utermann S, Bock M, Waldmann V. et al. Non - HIV Kaposi’s Sarcoma can be effectively treated with low dose interferon- alpha despite the persistence of herpesvirus-8. Br J Dermatol 1998; 139: 1052-4
  • 5 Hong A, Lee CS. Kaposi’s sarcoma: Clinico pathological analysis of HIV and non HIV associated cases. Pathol Oncol Res 2002; 8: 31-5
  • 6 Kanitakis J, Narvaez D, Claudy A. Expression of the CD 34 antigen distinguishes Kaposi’s sarcoma from Pseudo-Kaposi’s sarcoma (acroangiodermatitis). Br J Dermatol 1996; 134: 44-6